Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer

Original Article

S.J. Freedland, M.d.A. Luz, U.D. Giorgi, M. Gleave, G.T. Gotto, C.M. Pieczonka, G.P. Haas, C.-S. Kim, M. Ramirez-Backhaus, A. Rannikko, J. Tarazi, S. Sridharan, J. Sugg, Y. Tang, R.F.T. Jr., Jr., B. Venugopal, A. Villers, H.H. Woo, F. Zohren, and N.D. Shore

N Engl J Med 2023;389:1453-1465

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
10/18/2023
Course expires: 
10/19/2025
Take course

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Take course